72 related articles for article (PubMed ID: 16213721)
1. N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.
Grundt P; Kopajtic TA; Katz JL; Newman AH
Bioorg Med Chem Lett; 2005 Dec; 15(24):5419-23. PubMed ID: 16213721
[TBL] [Abstract][Full Text] [Related]
2. The effect of 6-substituted-4',4"-difluorobenztropines on monoamine transporters and the muscarinic M1 receptor.
Grundt P; Kopajtic TA; Katz JL; Newman AH
Bioorg Med Chem Lett; 2004 Jun; 14(12):3295-8. PubMed ID: 15149693
[TBL] [Abstract][Full Text] [Related]
3. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
Zou MF; Cao J; Kopajtic T; Desai RI; Katz JL; Newman AH
J Med Chem; 2006 Oct; 49(21):6391-9. PubMed ID: 17034144
[TBL] [Abstract][Full Text] [Related]
6. Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter.
Simoni D; Roberti M; Rondanin R; Baruchello R; Rossi M; Invidiata FP; Merighi S; Varani K; Gessi S; Borea PA; Marino S; Cavallini S; Bianchi C; Siniscalchi A
Bioorg Med Chem Lett; 2001 Mar; 11(6):823-7. PubMed ID: 11277529
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes.
Jean B; Surratt CK; Madura JD
J Mol Graph Model; 2017 Sep; 76():143-151. PubMed ID: 28734204
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
Katz JL; Kopajtic TA; Agoston GE; Newman AH
J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
[TBL] [Abstract][Full Text] [Related]
9. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
Mortensen OV; Amara SG
J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
[TBL] [Abstract][Full Text] [Related]
10. Dopamine Transporter Dynamics of
Hong WC; Wasko MJ; Wilkinson DS; Hiranita T; Li L; Hayashi S; Snell DB; Madura JD; Surratt CK; Katz JL
J Pharmacol Exp Ther; 2018 Sep; 366(3):527-540. PubMed ID: 29945932
[TBL] [Abstract][Full Text] [Related]
11. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
[TBL] [Abstract][Full Text] [Related]
12. Putative drug binding conformations of monoamine transporters.
Ravna AW; Sylte I; Kristiansen K; Dahl SG
Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
[TBL] [Abstract][Full Text] [Related]
13. N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects.
Li SM; Kopajtic TA; O'Callaghan MJ; Agoston GE; Cao J; Newman AH; Katz JL
J Pharmacol Exp Ther; 2011 Feb; 336(2):575-85. PubMed ID: 21088247
[TBL] [Abstract][Full Text] [Related]
14. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
15. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
16. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
17. Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H(1) receptors.
Kulkarni SS; Kopajtic TA; Katz JL; Newman AH
Bioorg Med Chem; 2006 Jun; 14(11):3625-34. PubMed ID: 16460947
[TBL] [Abstract][Full Text] [Related]
18. The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands.
Dar DE; Mayo C; Uhl GR
Biochem Pharmacol; 2005 Aug; 70(3):461-9. PubMed ID: 15950948
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and monoamine transporter binding of 2-(diarylmethoxymethyl)-3 beta-aryltropane derivatives.
Xu L; Kulkarni SS; Izenwasser S; Katz JL; Kopajtic T; Lomenzo SA; Newman AH; Trudell ML
J Med Chem; 2004 Mar; 47(7):1676-82. PubMed ID: 15027858
[TBL] [Abstract][Full Text] [Related]
20. Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats.
Tanda G; Ebbs AL; Kopajtic TA; Elias LM; Campbell BL; Newman AH; Katz JL
J Pharmacol Exp Ther; 2007 Apr; 321(1):334-44. PubMed ID: 17255465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
